A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
Clinical trial NCT00506441 · COMPLETED
Trial details
- NCT number
- NCT00506441
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2009-09-01
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.